Ishii Tatsu, Matsubara Takumi, Taira Hiroshi, Hiratsuka Yoshiharu
Department of Urology, Chikushi Hospital, Fukuoka University, Chikushino, Japan.
Nihon Hinyokika Gakkai Zasshi. 2013 May;104(3):540-4. doi: 10.5980/jpnjurol.104.540.
A 69-year-old man was admitted to our hospital with a chief complaint of lymphatic edema of left arm. He had a past history of transurethral resection of the bladder tumor 5 years ago, and pathological diagnosis was urothelial carcinoma with micropapillary variant, G3 = G2, pT1. CT scan revealed bladder tumor with invasion of the rectum, and multiple lymph nodes swelling in the axilla, retroperitoneum and pelvis (cT4bN3M1). The patient underwent biopsies of the bladder wall and the left axillary lymph nodes, and pathologic examination revealed micropapillary carcinoma. Five courses of gemcitabine plus cisplatin (GC therapy) were perfomed, and bladder tumor and lymph node metastases reduced remarkably, with serum CA19-9 level decreasing from 172,000 U/ml to 106 U/ml. However, the patient died from recurrence 23 months after the start of GC therapy.
一名69岁男性因左臂淋巴水肿为主诉入院。他5年前有经尿道膀胱肿瘤切除术史,病理诊断为微乳头变型尿路上皮癌,G3 = G2,pT1。CT扫描显示膀胱肿瘤侵犯直肠,腋窝、腹膜后和盆腔多个淋巴结肿大(cT4bN3M1)。患者接受了膀胱壁和左腋窝淋巴结活检,病理检查显示为微乳头癌。进行了5个周期的吉西他滨联合顺铂(GC方案)治疗,膀胱肿瘤和淋巴结转移明显减少,血清CA19-9水平从172,000 U/ml降至106 U/ml。然而,患者在GC治疗开始后23个月因复发死亡。